Search results
Results from the WOW.Com Content Network
The Dana–Farber/Harvard Cancer Center is the largest National Cancer Institute (NCI) designated Comprehensive Cancer Center in the nation. Founded in 1997, DF/HCC is an inter-institutional research enterprise that unites all of the cancer research efforts of the Harvard affiliated community. The primary goal of the Cancer Center is to ...
wulab .dfci .harvard .edu. Catherine J. Wu is an American physician-scientist who studies oncology. She is a Professor of Medicine and Chief of Division of Stem Cell Transplantation and Cellular Therapies at the Dana–Farber Cancer Institute. Her research focuses on longitudinal studies of patients with chronic lymphocytic leukemia (CLL).
The Jimmy Fund, established in Boston in 1948, is made up of community-based fundraising events and other programs that benefit Dana-Farber Cancer Institute. Since 1948, millions of people have given money to the Jimmy Fund to help save lives and reduce the burden of cancer for patients and families worldwide. [2]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Dana–Farber Cancer Institute. Sidney Farber (September 30, 1903 – March 30, 1973) was an American pediatric pathologist. He is regarded as the father of modern chemotherapy for his work using folic acid antagonists to combat leukemia, which led to the development of other chemotherapeutic agents against other malignancies.
The new Dana-Farber logo is known as “The Lens” because its iconography implies looking through a microscope, representing the interplay of research and treatment at Dana-Farber, with the ...
Ng has an undergraduate degree from Yale University (1997) and earned her M.D. from the University of Pennsylvania in 2001. Subsequently she trained at the University of California, San Francisco and Dana–Farber Cancer Institute. In 2007, she received a masters in public health from Harvard University.
Kenneth C. Anderson is an American hematologist-oncologist and cancer researcher who is primarily known for advances in the treatment of multiple myeloma. He directs the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana–Farber Cancer Institute and is the Kraft Family Professor of Medicine and Vice Chair of the ...